TABITUXIMAB BARZUXETAN
UNII 3K3IOQ7Q1K

Substance Identification & Data

This profile provides standardized clinical and technical data for Tabituximab Barzuxetan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3K3IOQ7Q1K.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1612758-88-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
3K3IOQ7Q1K
CAS Registry Number
1612758-88-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
TABITUXIMAB BARZUXETAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C166680
National Cancer Institute reference terminology for clinical and research data.
INN ID
10232
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tabituximab Barzuxetan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TABITUXIMAB BARZUXETAN

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(FRIZZLED RECEPTOR FRIZZLED-10) (HUMAN-MUS MUSCULUS MONOCLONAL OTSA101 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL OTSA101 LIGHT CHAIN, DIMER, COMPD. WITH N-((1S,2S)-2-(BIS(CARBOXYMETHYL)AMINO)CYCLOHEXYL)-N-((2R)-2-(BIS(CARBOXYMETHYL)AMINO)-3-(4-ISOTHIOCYANATOPHENYL)PROPYL)GLYCINE
TABITUXIMAB BARZUXETAN [INN]

Technical Codes

OTSA-101-DTPA

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus